Together, these findings suggest that PRMT7 ablation in ECs exacerbates MI-induced cardiomyopathy by dysregulating gene expression related to angiogenesis, cell proliferation and apoptotic processes. The gene discussed is PRMT7; the disease is cardiomyopathy.